from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3446c/-

LFCtreatmentdescriptionclass of inhibitor

-0.753

Amikacinug/mL Amikacintranslation

0.571

Cap5-10ug/mL Capreomycintranslation

-0.757

Rox10-50 ug/mL Roxithromycintranslation

0.323

SM2-5 ug/mL Streptomycintranslation

0.170

Tet5-10 ug/mL Tetracyclinetranslation

-1.520

Rif0.2-5ug/mL Rifampicintranscription

-0.302

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.067

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.059

CPZ10-50 ug/mL Chlorpromazinerespiration

2.099

Clofazimine10-13 ug/mL Clofaziminerespiration

0.715

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.670

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.258

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.733

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.245

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.529

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.745

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.176

Nigericin50 uM Nigericinrespiration

-0.968

TRC10-150 ug/mL Triclosanrespiration

1.645

TRZ10-25 ug/mL Thioridazinerespiration

0.961

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.592

menadione6-10 ug/mL Menadionerespiration

0.243

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.547

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.657

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.474

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.349

NRP_1Non-replicating persistence stage 1dosRassociated

0.653

Amp0.2mg/mL AmpicillincellWall

0.739

Cephalexin20-100 ug/mL CephalexincellWall

0.133

Cerulenin0.32-5 ug/mL CerulenincellWall

0.939

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.095

EMB10-20 ug/mL EthambutolcellWall

-0.525

Eta12-40 ug/mL EthionamidecellWall

0.018

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.442

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.383

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.294

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.403

BZA0.12 mg/mL BenzamidearomaticAmides

-0.632

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.456

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.029

H2O24 mM hydrogen peroxideDNAdamaging

0.212

Levo10 ug/mL LevofloxacinDNAdamaging

0.425

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.235

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.545

UVUV-irradiationDNAdamaging

1.116

ARP41-4 ug/mL Antitubercular compound ARP4?

0.245

Antimycin12.5-50 ug/mL Antimycin A?

0.308

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.415

PA_110-50 ug/mL Antitubercular compound PA-1?

0.558

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.123

PA8240.2-2 ug/mL PA-824?

-1.325

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.456

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.301

Verapamil50 uM Verapamil?

-0.129

mercaptoethanol2 mM 2-Mercaptoethanol?

0.850

methoxatin10-20 ug/mL Methoxatin?